Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema

Acta Ophthalmologica

Volumn 95, Issue 5, 2017, Pages 464-471

  Vujosevic, Stela ^a   Torresin, Tommaso ^a   Bini, Silvia ^a   Convento, Enrica ^a   Pilotto, Elisabetta ^a   Parrozzani, Raffaele ^b   Midena, Edoardo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

diabetic macular oedema; fundus autofluorescence; hyper reflective retinal spots; microperimetry; OCT; subfoveal neuroretinal detachment

Indexed keywords

DEXAMETHASONE; HEMOGLOBIN A1C; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; BEVACIZUMAB; BIOLOGICAL MARKER; DRUG IMPLANT; GLUCOCORTICOID; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETIC MACULAR EDEMA; DISEASE DURATION; EYE PHOTOGRAPHY; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERIMETRY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FOVEA; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; ANTAGONISTS AND INHIBITORS; COMBINATION DRUG THERAPY; COMPLICATION; DIABETIC RETINOPATHY; DRUG IMPLANT; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; METABOLISM; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA MACULA LUTEA;

ADULT; AGED; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; BIOMARKERS; DEXAMETHASONE; DIABETIC RETINOPATHY; DRUG IMPLANTS; DRUG THERAPY, COMBINATION; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MIDDLE AGED; RANIBIZUMAB; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84996866160     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.13294     Document Type: Article

References (35)

1. Aloisi F (2001): Immune function of microglia. Glia 36: 165–179.
2. Augustin A, Loewenstein A & Kuppermann BD (2010): Macular edema. General pathophysiology. Dev Ophthalmol 47: 10–26.
3. Bouïs D, Kusamanto Y, Meijer C, Mulder NH & Hospers GAP (2006): A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53: 89–103.
4. Coscas G, Coscas F, Vismara S, Zourdani A & Li Calzi CI (2009): Clinical features and natural history of AMD. In: Coscas G, Coscas F, Vismara S, Zourdani A & Li Calzi CI (eds.). Optical coherence tomography in age-related macular degeneration. Heidelberg: Springer 171–274.
5. Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Toraval F, Bandello F & Souied E (2013): Hyperreflective dots: a new spectral- domain optical coherence tomography entity for follow-up and prognosis in exudative age- related macular degeneration. Ophthalmologica 229: 32–37.
6. Das A, McGuire PG & Rangasamy S (2015): Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 122: 1375–1394.
7. Dong N, Xu B, Chu L & Tang X (2015): Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. PLoS One 10: e012532.
8. Forstreuter F, Lucius R & Mentlein R (2002): Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132: 93–98.
9. Framme C, Schweizer P, Imesch M, Wolf S & Wolf-Schnurrbusch U (2012): Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci 53: 5814–5818.
10. Funatsu H, Noma H, Mimura T, Eguchi S & Hori S (2009): Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116: 73–79.
11. Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ & Schmidt-Erfurth UM (2010): Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 30: 1412–1419.
12. Gaucher D, Sebah C, Erginay A, Haouchine B, Tadayoni R, Gaudric A & Massin P (2008): Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 145: 289–296.
13. Ishida S, Usui T, Yamashiro K et al. (2003): VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 44: 2155–2162.
14. Madeira MH, Boia R, Santos PF, Ambrósio AF & Santiago AR (2015): Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm 2015: 673090.
15. Nagaoka T, Kitaya N, Sugawara R et al. (2004): Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 88: 1060–1063.
16. Nehmé A & Edelman J (2008): Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes. Invest Ophthalmol Vis Sci 49: 2030–2038.
17. Omri S, Behar-Cohen F, de Kozak Y et al. (2011): Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKC#in the Goto Kakizaki rat model. Am J Pathol 179: 942–953.
18. Otani T, Kishi S & Maruyama Y (1999): Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127: 688–693.
19. Pece A, Isola V, Holz F, Milani P & Brancato R (2009): Autofluorescence imaging of cystoid macular edema in diabetic retinopathy. Ophthalmologica 224: 230–235.
20. Reznicek L, Dabov S, Haritoglou C et al. (2013): Green-light fundus autofluorescence in diabetic macular edema. Int J Ophthalmol 6: 75–80.
21. Schmitz-Valckenberg S, Holz FG, Bird AC & Spaide RF (2008): Fundus autofluorescence imaging: review and perspectives. Retina 28: 385–409.
22. Seo KH, Yu SY, Kim M & Kwak HW (2016): Visual and morphologic outcomes of intravitreal ranibizumab for diabetic macular edema based on optical coherence tomography patterns. Retina 36: 588–595.
23. Simo’ R & Hernandez C (2015): Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res 48: 160–180.
24. Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY & Nam DH (2011): Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 152: 686–694.
25. Sonoda S, Sakamoto T, Yamashita T, Shirasawa M, Otsuka H & Sonoda Y (2014): Retinal morphologic changes and concentrations of cytokines in eyes with diabetic macular edema. Retina 34: 741–748.
26. Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K & Yoshimura N (2005): Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46: 1440–1444.
27. Uckermann O, Kutzera F, Wolf A, Pannicke T, Reichenbach A, Wiedemann P, Wolf S & Bringmann A (2005): The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther 315: 1036–1045.
28. Vujosevic S, Midena E, Pilotto E et al. (2006): Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 47: 3044–3051.
29. Vujosevic S, Casciano M, Pilotto E et al. (2011): Diabetic macular edema: fundus autofluorescence and functional correlations. Invest Ophthalmol Vis Sci 52: 442–448.
30. Vujosevic S, Bini S, Midena G, Berton M, Pilotto E & Midena E (2013): Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res 2013: 491835.
31. Vujosevic S, Berton M, Bini S, Casciano M, Cavarzeran F & Midena E (2016a): Hyperreflective retinal spots and visual function after anti-VEGF treatment in center-involving diabetic macular edema. Retina 36: 1298–1308.
32. Vujosevic S, Micera A, Bini S, Berton M, Esposito G & Midena E (2016b): Proteome analysis of retinal glia cells-related inflammatory cytokines in the aqueous humour of diabetic patients. Acta Ophthalmol 94: 56–64.
33. Xu H, Chen M, Manivannan A, Lois N & Forrester JV (2008): Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 7: 58–68.
34. Yoshitake S, Murakami T, Uji A, Unoki N, Dodo Y, Horii T & Yoshimura N (2015): Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema. Eye (Lond) 29: 662–669.
35. Zhang X, Zeng H, Bao S, Wang N & Gillies MC (2014): Diabetic macular edema: new concepts in patho-physiology and treatment. Cell Biosci 4: 4–27.